Cargando…

New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease

Hyperkalemia may cause life-threatening cardiac and neuromuscular alterations, and it is associated with high mortality rates. Its treatment includes a multifaceted approach, guided by potassium levels and clinical presentation. In general, treatment of hyperkalemia may be directed towards stabilizi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Pasquale, Conti, Novella Evelina, Falqui, Valeria, Cipriani, Leda, Picciotto, Daniela, Costigliolo, Francesca, Garibotto, Giacomo, Saio, Michela, Viazzi, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465118/ https://www.ncbi.nlm.nih.gov/pubmed/32707890 http://dx.doi.org/10.3390/jcm9082337

Ejemplares similares

Nutritional Challenges in Pregnant Women with Renal Diseases: Relevance to Fetal Outcomes
por: Esposito, Pasquale, et al.
Publicado: (2020)

Homocysteine exchange across skeletal muscle in patients with chronic kidney disease
por: Garibotto, Giacomo, et al.
Publicado: (2023)

Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification
por: Esposito, Pasquale, et al.
Publicado: (2021)

Low Protein Diets and Plant-Based Low Protein Diets: Do They Meet Protein Requirements of Patients with Chronic Kidney Disease?
por: Verzola, Daniela, et al.
Publicado: (2020)

Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy
por: Verzola, Daniela, et al.
Publicado: (2020)

Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
por: Esposito, Pasquale, et al.
Publicado: (2023)

How to Overcome Anabolic Resistance in Dialysis-Treated Patients?
por: Garibotto, Giacomo, et al.
Publicado: (2021)

The Evolving Scenario of COVID-19 in Hemodialysis Patients
por: Esposito, Pasquale, et al.
Publicado: (2022)

The Contribution of Muscle Innate Immunity to Uremic Cachexia
por: Esposito, Pasquale, et al.
Publicado: (2023)

Treatment of Chronic Kidney Disease: Moving Forward
por: Garibotto, Giacomo, et al.
Publicado: (2022)

Activin/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A “liaison dangereuse”?
por: Garibotto, Giacomo, et al.
Publicado: (2019)

Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy
por: Russo, Elisa, et al.
Publicado: (2020)

Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review
por: Esposito, Pasquale, et al.
Publicado: (2023)

Kidney Transplantation in a Patient Affected by Sickle Cell Trait: A Case Report and State-of-the-Art Review
por: Picciotto, Daniela, et al.
Publicado: (2023)

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
por: Russo, Elisa, et al.
Publicado: (2023)

Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial
por: Esposito, Pasquale, et al.
Publicado: (2021)

Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs
por: Russo, Elisa, et al.
Publicado: (2023)

Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study
por: Esposito, Pasquale, et al.
Publicado: (2022)

Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
por: Russo, Elisa, et al.
Publicado: (2020)

Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway
por: Milanesi, Samantha, et al.
Publicado: (2019)

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis
por: Garibotto, Giacomo, et al.
Publicado: (2015)

New options for the management of chronic hyperkalemia
por: Fried, Linda, et al.
Publicado: (2017)

Toll‐like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease
por: Verzola, Daniela, et al.
Publicado: (2016)

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
por: Morales, Enrique, et al.
Publicado: (2021)

Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4
por: Verzola, Daniela, et al.
Publicado: (2014)

Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
por: Calabrese, Vincenzo, et al.
Publicado: (2022)

Longitudinal Cluster Analysis of Hemodialysis Patients with COVID-19 in the Pre-Vaccination Era
por: Esposito, Pasquale, et al.
Publicado: (2022)

Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
por: Sarnowski, Alexander, et al.
Publicado: (2022)

Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease
por: Kim, Gheun-Ho
Publicado: (2019)

Chronic kidney disease as a predictor of clinical risk in the elderly
por: Viazzi, Francesca, et al.
Publicado: (2016)

A Changing Perspective for Treatment of Chronic Kidney Disease
por: Garibotto, Giacomo
Publicado: (2021)

Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports
por: Esposito, Pasquale, et al.
Publicado: (2023)

Stress-Dose Steroids: A Potential Therapeutic Option for Refractory Hyperkalemia
por: Zardoost, Pooya, et al.
Publicado: (2023)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease
por: Jo, Sang Min
Publicado: (2023)

Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia
por: Cook, Erin E., et al.
Publicado: (2021)

Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia
por: Israni, Rubeen, et al.
Publicado: (2021)

Effects of Low-Protein, and Supplemented Very Low–Protein Diets, on Muscle Protein Turnover in Patients With CKD
por: Garibotto, Giacomo, et al.
Publicado: (2018)

RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study
por: Riccio, Eleonora, et al.
Publicado: (2022)

Hyperkalemia and Rhabdomyolyssis
por: Yasri, Sora, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_52hdrd0e4ce8aq1g2kgijjbio6